Table 2 Prognostic value of RABEX-5 mRNA expression for the biochemical recurrence free survival in univariate and multivariate analyses by Cox regression
From: Expression of RABEX-5 and its clinical significance in prostate cancer
Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|
Covariant | Exp (B) | 95% CI | P value | Exp (B) | 95% CI | P value |
RABEX-5 mRNA expression | 1.716 | 1.207-2.439 | 0.003 | 1.642 | 1.154-2.337 | 0.006 |
Gleason score | 1.703 | 1.280-2.265 | <0.001 | 1.674 | 1.259-2.225 | <0.001 |
Seminal vesicle invasion | 1.505 | 1.132-2.003 | 0.005 | 1.443 | 1.084-1.920 | 0.012 |
Preoperative PSA | 1.241 | 0.705-2.188 | 0.454 | |||
Angiolymphatic invasion | 1.084 | 0.814-1.443 | 0.580 | |||
Surgical margin status | 1.017 | 0.709-1.459 | 0.925 | |||
PCa Stage | 1.090 | 0.921-1.291 | 0.316 | |||
Lymph node metastasis | 1.140 | 0.850-1.528 | 0.381 | |||
Age | 1.068 | 0.804-1.419 | 0.650 | |||